과제정보
연구 과제 주관 기관 : Ministry for Health, Welfare & Family Affairs
참고문헌
- Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8. https://doi.org/10.1056/NEJM199206113262403
- Araujo CM, Souhami L, Gil RA, et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991;67:2258-61. https://doi.org/10.1002/1097-0142(19910501)67:9<2258::AID-CNCR2820670908>3.0.CO;2-G
- Tachimori Y. Role of salvage esophagectomy after definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg 2009;57:71-8 https://doi.org/10.1007/s11748-008-0337-5
- Fakhrian K, Gamisch N, Schuster T, Thamm R, Molls M, Geinitz H. Salvage radiotherapy in patients with recurrent esophageal carcinoma. Strahlenther Onkol 2012;188:136-42. https://doi.org/10.1007/s00066-011-0023-x
- Yano M, Takachi K, Doki Y, et al. Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer. Dis Esophagus 2006;19:73-7. https://doi.org/10.1111/j.1442-2050.2006.00543.x
- Shioyama Y, Nakamura K, Ohga S, et al. Radiation therapy for recurrent esophageal cancer after surgery: clinical results andprognostic factors. Jpn J Clin Oncol 2007;37:918-23. https://doi.org/10.1093/jjco/hym138
- Morita M, Kumashiro R, Hisamatsu Y, et al. Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. J Gastroenterol 2011;46:1284-91. https://doi.org/10.1007/s00535-011-0448-0
- Yano T, Muto M, Hattori S, et al. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 2008;40:717-21. https://doi.org/10.1055/s-2008-1077480
- Hattori S, Muto M, Ohtsu A, et al. EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 2003;58:65-70. https://doi.org/10.1067/mge.2003.306
- Harms W, Krempien R, Grehn C, Berns C, Hensley FW, Debus J. Daytime pulsed dose rate brachytherapy as a new treatment option for previously irradiated patients with recurrent oesophageal cancer. Br J Radiol 2005;78:236-41. https://doi.org/10.1259/bjr/51982166
- Yamaguchi S, Ohguri T, Imada H, et al. Multimodal approaches including three-dimensional conformal re-irradiation for recurrent or persistent esophageal cancer: preliminary results. J Radiat Res 2011;52:812-20. https://doi.org/10.1269/jrr.11066
- Nonoshita T, Sasaki T, Hirata H, et al. High-dose-rate brachytherapy for previously irradiated patients with recurrent esophageal cancer. Radiat Med 2007;25:373-7. https://doi.org/10.1007/s11604-007-0152-4
- Teli MA, Mushood GN, Zargar SA, Andrabi WH. Comparative evaluation between re-irradiation and demand endoscopic dilatation vs endoscopic dilatation alone in patients with recurrent/reactivated residual in-field esophageal malignancies. J Cancer Res Ther 2008;4:121-5. https://doi.org/10.4103/0973-1482.43140
- Russo JK, Rosen L. TomoTherapy stereotactic body radiation therapy (SBRT) for the salvage treatment of locally recurrent esophageal adenocarcinoma following trimodality therapy: a case report. Tumori 2011;97:406-10.
- Sharma V, Mahantshetty U, Dinshaw KA, Deshpande R, Sharma S. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2002;52:310-5. https://doi.org/10.1016/S0360-3016(01)01822-3
피인용 문헌
- The Efficacy and Safety of Re-Irradiation for 18 Patients with Malignant Tumor vol.2, pp.4, 2012, https://doi.org/10.12677/acrpo.2013.24005
- An Unusual Course of Metastatic Gastroesophageal Cancer vol.2015, pp.None, 2012, https://doi.org/10.1155/2015/941508
- Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair vol.8, pp.None, 2012, https://doi.org/10.2147/ott.s76958
- High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer : Experience from a large single-center cohort vol.192, pp.7, 2016, https://doi.org/10.1007/s00066-016-0979-7
- Stereotactic radiotherapy in the treatment of local recurrences of esophageal cancer vol.13, pp.3, 2012, https://doi.org/10.3892/ol.2017.5605
- Re-irradiation of locoregional esophageal cancer recurrence following definitive chemoradiotherapy: A report of 6 cases vol.7, pp.4, 2012, https://doi.org/10.3892/mco.2017.1384
- Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study vol.12, pp.None, 2012, https://doi.org/10.1186/s13014-017-0882-0
- Clinical application of oral meglumine diatrizoate esophagogram in screening esophageal fistula during radiotherapy for esophageal cancer vol.97, pp.18, 2012, https://doi.org/10.1097/md.0000000000010668
- Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy : Study protocol for a prospective multi-center phase II trial vol.98, pp.26, 2012, https://doi.org/10.1097/md.0000000000016176
- Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy vol.14, pp.1, 2019, https://doi.org/10.1186/s13014-019-1402-1
- Risk Factors for Esophageal Fistula in Esophageal Cancer Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis vol.43, pp.1, 2012, https://doi.org/10.1159/000503754
- Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma vol.11, pp.12, 2012, https://doi.org/10.7150/jca.39033
- Definitive re-irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance status vol.13, pp.1, 2012, https://doi.org/10.3892/mco.2020.2044
- Assessing Outcomes of Patients Treated With Re-Irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction vol.15, pp.6, 2012, https://doi.org/10.1016/j.jtho.2020.01.024
- Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis vol.15, pp.1, 2012, https://doi.org/10.1186/s13014-020-01685-2
- Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees vol.11, pp.None, 2012, https://doi.org/10.3389/fonc.2021.748331
- A Phase II Study of Apatinib in Patients with Chemotherapy‐Refractory Esophageal Squamous Cell Carcinoma (ESO‐Shanghai 11) vol.26, pp.6, 2012, https://doi.org/10.1002/onco.13668
- Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma vol.5, pp.4, 2021, https://doi.org/10.1002/ags3.12448
- A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy vol.16, pp.1, 2012, https://doi.org/10.1186/s13014-021-01828-z